106 related articles for article (PubMed ID: 24355005)
21. Cystic fibrosis mutation frequencies in an Irish population.
Devaney J; Glennon M; Farrell G; Ruttledge M; Smith T; Houghton JA; Maher M
Clin Genet; 2003 Feb; 63(2):121-5. PubMed ID: 12630958
[TBL] [Abstract][Full Text] [Related]
22. [Frequency of mutations and genotypes of the CFTR gene in cystic fibrosis adults in Poland].
Witt M; Pogorzelski A; Bal J; Rutkiewicz E; Majka L; Sobczyńska A
Pneumonol Alergol Pol; 1999; 67(3-4):137-41. PubMed ID: 10497446
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
[TBL] [Abstract][Full Text] [Related]
24. Modifying effect of HLA haplotypes located trans to DQB1*02-DRB1*03 in celiac patients of Southern Europe.
Hernández-Charro B; Donat E; Miner I; Aranburu E; Sánchez-Valverde F; Ramos-Arroyo MA
Tissue Antigens; 2008 Mar; 71(3):213-8. PubMed ID: 18257894
[TBL] [Abstract][Full Text] [Related]
25. Identification of a cystic fibrosis mutation W19X in Tunisia.
Boudaya M; Fredj SH; Siala H; Bibi A; Messaoud T
Ann Biol Clin (Paris); 2013; 71(2):223-6. PubMed ID: 23587593
[TBL] [Abstract][Full Text] [Related]
26. Genetic variations in toll-like receptor pathway and lung function decline in Cystic fibrosis patients.
Haerynck F; Mahachie John JM; Van Steen K; Schelstraete P; Van daele S; Loeys B; Van Thielen M; De Canck I; Nuytinck L; De Baets F
Hum Immunol; 2013 Dec; 74(12):1649-55. PubMed ID: 23994582
[TBL] [Abstract][Full Text] [Related]
27. Association between HLA-DQB1*03:01 and Bullous pemphigoid in Iranian patients.
Esmaili N; Mortazavi H; Chams-Davatchi C; Daneshpazhooh M; Damavandi MR; Aryanian Z; Amirzargar AA
Iran J Immunol; 2013 Mar; 10(1):1-9. PubMed ID: 23502333
[TBL] [Abstract][Full Text] [Related]
28. [Study on the polymorphisme of human leucocyte antigen-DRB1, -DQA1 and -DQB1 alleles in patients with hepatitis B].
Jiang YG; Wang YM
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Apr; 25(4):337-40. PubMed ID: 15231205
[TBL] [Abstract][Full Text] [Related]
29. [Relation between gene mutations and pancreatic exocrine function in patients with cystic fibrosis].
Radivojević D; Guć-Sćekić M; Djurisić M; Lalić T; Minić P; Kanavakis E
Srp Arh Celok Lek; 2001; 129 Suppl 1():6-9. PubMed ID: 15637983
[TBL] [Abstract][Full Text] [Related]
30. Is the hemochromatosis gene a modifier locus for cystic fibrosis?
Rohlfs EM; Shaheen NJ; Silverman LM
Genet Test; 1998; 2(1):85-8. PubMed ID: 10464603
[TBL] [Abstract][Full Text] [Related]
31. HLA associations with tubulointerstitial nephritis with or without uveitis in Finnish pediatric population: a nation-wide study.
Peräsaari J; Saarela V; Nikkilä J; Ala-Houhala M; Arikoski P; Kataja J; Rönnholm K; Merenmies J; Nuutinen M; Jahnukainen T
Tissue Antigens; 2013 Jun; 81(6):435-41. PubMed ID: 23594347
[TBL] [Abstract][Full Text] [Related]
32. Modifier genes in cystic fibrosis lung disease.
Merlo CA; Boyle MP
J Lab Clin Med; 2003 Apr; 141(4):237-41. PubMed ID: 12677168
[TBL] [Abstract][Full Text] [Related]
33. Aquagenic wrinkling of the palms in cystic fibrosis: comparison with controls and genotype-phenotype correlations.
Berk DR; Ciliberto HM; Sweet SC; Ferkol TW; Bayliss SJ
Arch Dermatol; 2009 Nov; 145(11):1296-9. PubMed ID: 19917960
[TBL] [Abstract][Full Text] [Related]
34. [Possible association between polymorphisms of human leukocyte antigen-DQ genes and susceptibility to trichloroethylene-induced severe generalized dermatitis].
Li HS; Dai YF; Huang HL; Feng XL; Sun YF; Niu Y; Cheng J; Zhang LY; Li LY; Chen B; Zheng YX
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 May; 40(3):173-6. PubMed ID: 16836882
[TBL] [Abstract][Full Text] [Related]
35. Spatial and temporal distribution of cystic fibrosis and of its mutations in Brittany, France: a retrospective study from 1960.
Scotet V; Gillet D; Duguépéroux I; Audrézet MP; Bellis G; Garnier B; Roussey M; Rault G; Parent P; De Braekeleer M; Férec C;
Hum Genet; 2002 Sep; 111(3):247-54. PubMed ID: 12215837
[TBL] [Abstract][Full Text] [Related]
36. HLA serological and class II genotyping in sarcoidosis patients in Japan.
Ishihara M; Ishida T; Inoko H; Ando H; Naruse T; Nose Y; Ohno S
Jpn J Ophthalmol; 1996; 40(1):86-94. PubMed ID: 8739505
[TBL] [Abstract][Full Text] [Related]
37. Cystic fibrosis in Uruguay.
Luzardo G; Aznarez I; Crispino B; Mimbacas A; Martínez L; Poggio R; Zielenski J; Tsui LC; Cardoso H
Genet Mol Res; 2002 Mar; 1(1):32-8. PubMed ID: 14963811
[TBL] [Abstract][Full Text] [Related]
38. HLA-class II alleles in Egyptian patients with hepatocellular carcinoma.
El-Chennawi FA; Auf FA; Metwally SS; Mosaad YM; El-Wahab MA; Tawhid ZE
Immunol Invest; 2008; 37(7):661-74. PubMed ID: 18821214
[TBL] [Abstract][Full Text] [Related]
39. Association of MP6d9 Polymorphism with Clinical Variability in Cystic Fibrosis Patients.
Sahli C; Hadj-Fredj S; Dabboubi R; Bousseta K; Mehrzi A; Messaoud T
Clin Lab; 2016 Nov; 62(11):2139-2143. PubMed ID: 28164663
[TBL] [Abstract][Full Text] [Related]
40. Co-amplification of the cystic fibrosis delta F508 mutation with the HLA DQA1 sequence in single cell PCR: implications for improved assessment of polar bodies and blastomeres in preimplantation diagnosis.
Wu R; Cuppens H; Buyse I; Decorte R; Marynen P; Gordts S; Cassiman JJ
Prenat Diagn; 1993 Dec; 13(12):1111-22. PubMed ID: 7513888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
